PTC Therapeutics Aktie
60,00
EUR
-0,50
EUR
-0,83
%
71,65
USD
-2,47
USD
-3,33
%
Werbung
PTC Therapeutics Aktie Analyse
| 29.01.18 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
| 29.09.17 | PTC Therapeutics Equal weight | Barclays Capital | |
| 29.09.17 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
| 16.03.17 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
| 03.03.17 | PTC Therapeutics Equal weight | Barclays Capital | |
| 11.11.16 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
| 01.03.16 | PTC Therapeutics Neutral | Wedbush Morgan Securities Inc. | |
| 01.03.16 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
|
Werbung
|
|||
| 24.02.16 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
| 05.05.15 | PTC Therapeutics Neutral | ROTH Capital Partners, LLC | |
Werbung
Werbung